Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122669) titled 'Development and Validation of a Urinary cfDNA Fragmentomics Assay for Early Detection of Urologic Tumors' on April 16.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Genitourinary Tumors (Bladder Cancer, Kidney Cancer, Prostate Cancer)
Intervention:
Urinary Tumor Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Urinary Tumor Group:206;Non-cancer Control Group:104;
Countries of Recruitment:
China
To know more, v...